TFBS Bioscience Inc. (TPEX: 6939)
Health Care · Life Sciences Tools & Services · TW
NT$19.65
+0.77% today · -20.4% 1Y
TFBS Bioscience Inc. (TPEX: 6939) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $21.46M and employs 85 people.
Over the last twelve months the share price has lost 20.4%, trading between 18.50 and 29.25.
6939 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.46M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- NT$29.25
- 52-week low
- NT$18.50
- Avg volume (3M)
- —
- Shares outstanding
- 34.94M
- Employees
- 85
- Next earnings
- —
About TFBS Bioscience Inc.
TFBS Bioscience Inc. functions as a contract research organization (CRO), specializing in offering biological analysis and testing services throughout Taiwan. The company plays a crucial role in supporting advanced medical innovations by fabricating viral vectors, which are essential for cell and gene therapy products. Furthermore, TFBS Bioscience conducts comprehensive biosafety and final product release evaluations for a diverse range of biopharmaceutical items, including cell and gene therapies, vaccines, and other biologics. Established in 2016, the firm's main operational base is located in New Taipei City, Taiwan.
- ISIN
- TW0006939002
- Founded
- 2016
- Listed since
- May 16, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $635.73 | +1.21% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.54 | -0.20% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF587.80 | -1.01% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $154.49 | -0.18% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.31 | +0.73% |
| Waters CorporationNYSE: WAT | $40.72B | $414.79 | +0.08% |
Figures last refreshed Aug 18, 2026.